The latest news from oncology events around the world
A new genomic test designed to measure endocrine sensitivity of estrogen receptor-positive breast cancer has…
To fully evaluate hormone-blocking therapy following surgery for patients with early-stage high-risk HR+/HER2- breast cancer,…
Nearly one million people in the United States are affected by Lynch syndrome – a…
Combination immunotherapy treatment with anti-PD-1 and anti-CTLA-4 checkpoint inhibitors has proven effective as a front-line option for many patients…
Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer caused by…
Most head and neck cancer patients treated with radiation therapy develop long-term treatment-related dry mouth, or xerostomia,…
Cancer-related fatigue (CRF) is the most common symptom in patients with cancer, and there are limited…
To be presented at the American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June…
Australia is facing a looming skills shortage to deal with a predicted 50 per cent…
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in…